Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
followed so far, and to suggest appropriate next steps. The key technology for developing this tool will be the IDP-Z3 reasoning engine . The research will be carried out within the Artificial Intelligence
-
%) doctoral scholarship holder in the field of CRISPR/Cas-mediated photoelectrochemical biosensors. The overall goal of this PhD is the development of photoelectrochemical biosensors integrating CRISPR/Cas
-
collaborated with ULB's ATM research group under the name VUB-ULB Joint Research Group BRITE (Brussels Institute for Thermal-fluid Systems and clean Energy). FLOW's research focuses on the development
-
in A. thaliana and wheat, which we started to functionally characterize. The Vascular Development group (https://www.derybellab.be), studies plant vascular development at the interface between
-
most prominent universities, consistently ranked in the top 50 worldwide. Leuven is located 10 miles from Brussels, with frequent direct train connections to Brussels airport. Profile PhD in a
-
that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently composed
-
most prominent universities, consistently ranked in the top 50 worldwide. Leuven is located 10 miles from Brussels, with frequent direct train connections to Brussels airport. Profile PhD in a
-
scientist to study the human-specific genetic mechanisms of development and function of cortical neurons. Join us to undertake a highly interdisciplinary project focusing on a long-standing and fascinating
-
scientist to study the human-specific genetic mechanisms of development and function of cortical neurons. Join us to undertake a highly interdisciplinary project focusing on a long-standing and fascinating
-
of the biology that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently